| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 40.9964 | 9 |
| GSM780708 | Untreated after 4 days (C2_1) | 53.0581 | 56 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.8257 | 31 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.2446 | 19 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.8138 | 21 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.6988 | 21 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.06 | 32 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 39.8795 | 6 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.1121 | 28 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 40.766 | 9 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 39.6572 | 6 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 42.1463 | 14 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 38.8884 | 4 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 49.3139 | 46 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.7114 | 31 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.1013 | 18 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 42.0376 | 13 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.761 | 31 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 37.5408 | 2 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 39.6906 | 6 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 42.7408 | 16 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.0101 | 32 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.495 | 25 |